Bench-to-bedside drug design could lead to new Alzheimer’s disease treatments

An international team of scientists and pharmaceutical collaborators has made a breakthrough “bench to bedside” discovery, ten years in the making, which they hope will advance the future treatment of Alzheimer’s disease in patients.